ABCG2 and retinoblastoma: Our results showed that single exposure to chemotherapy or even longer and continuous treatments with melphalan or topotecan at the IC50 did not alter ABCB1, ABCC1, or ABCG2 expression levels in retinoblastoma and HUVEC cells.